|
[1]
|
Glucose metabolism and lncRNAs in breast cancer: Sworn friend
Cancer Medicine,
2023
DOI:10.1002/cam4.5265
|
|
|
|
|
[2]
|
Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma
Libyan Journal of Medicine,
2023
DOI:10.1080/19932820.2023.2283953
|
|
|
|
|
[3]
|
Antiglycolytic Activities of Strobilanthes crispus Active Fraction and its Bioactive
Components on Triple-Negative Breast Cancer Cells In Vitro
Anti-Cancer Agents in Medicinal Chemistry,
2022
DOI:10.2174/1871520621666210427104804
|
|
|
|
|
[4]
|
Determine the glucose regulatory role of decaffeinated Green Tea extract in reduces the metastasis and cell viability of MCF7 cell line
1ST SAMARRA INTERNATIONAL CONFERENCE FOR PURE AND APPLIED SCIENCES (SICPS2021): SICPS2021,
2022
DOI:10.1063/5.0121367
|
|
|
|
|
[5]
|
An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
Frontiers in Pharmacology,
2022
DOI:10.3389/fphar.2022.1035510
|
|
|
|
|
[6]
|
Glucose metabolism and lncRNAs in breast cancer: Sworn friend
Cancer Medicine,
2022
DOI:10.1002/cam4.5265
|
|
|
|
|
[7]
|
Gold Nanoparticles; Potential Nanotheranostic Agent in Breast Cancer: A Comprehensive Review with Systematic Search Strategy
Current Drug Metabolism,
2020
DOI:10.2174/1389200221666200610173724
|
|
|
|
|
[8]
|
Challenges and perspectives in the treatment of diabetes associated breast cancer
Cancer Treatment Reviews,
2018
DOI:10.1016/j.ctrv.2018.08.004
|
|
|
|
|
[9]
|
Differential response to exercise in claudin-low breast cancer
Oncotarget,
2017
DOI:10.18632/oncotarget.21054
|
|
|
|
|
[10]
|
Potential survival markers in cancer patients undergoing chemotherapy
Clinical and Experimental Medicine,
2015
DOI:10.1007/s10238-014-0313-6
|
|
|
|